A Phase II, Double-blind, Dose-Ranging, Parallel, Long-term Extension Study to Evaluate the Safety and Efficacy of Enpatoran in Participants with Subacute Cutaneous Lupus Erythematosus, Discoid Lupus Erythematosus and/or Systemic Lupus Erythematosus Having Completed the WILLOW (MS200569_0003) Study Treatment

Project: Research

Project Details

Project Description

HREC Reference Number: HREC/86667/MH-2022
SSA Reference Number: SSA/86667/MonH-2022-345324(v2)
ERM Reference Number: 86667
Monash Health Reference: RES-22-0000-690X
StatusActive
Effective start/end date6/03/23 → 5/03/28